Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Community Health|August 18, 2015
Predictors of Obesity in a Cohort of Children Enrolled in WIC as Infants and Retained to 3 Years of AgeM A Chiasson, R Scheinmann, D Hartel, et al.
General Hospital Psychiatry|November 1, 1993
A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patientsC H Silberstein, M A O'Dowd, P Chartock, et al.
American Journal of Public Health|August 1, 1996
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NYM N Gourevitch, D Hartel, E E Schoenbaum, et al.
The New England Journal of Medicine|September 28, 1989
Risk factors for human immunodeficiency virus infection in intravenous drug usersE E Schoenbaum, D Hartel, P A Selwyn, et al.
The New England Journal of Medicine|December 10, 1992
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infectionP A Selwyn, P Alcabes, D Hartel, et al.
AIDS (London, England)|January 1, 1994
Laboratory markers and the risk of developing HIV-1 disease among injecting drug usersP Alcabes, P A Selwyn, K Davenny, et al.
The Journal of Infectious Diseases|February 1, 1991
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?R F Khabbaz, D Hartel, M Lairmore, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 24, 1997
Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug usersK A Holbrook, R S Klein, D Hartel, et al.
AIDS (London, England)|August 1, 1988
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDSP A Selwyn, A R Feingold, D Hartel, et al.
The New England Journal of Medicine|March 2, 1989
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infectionP A Selwyn, D Hartel, V A Lewis, et al.
Pageof 3